Close

Heat Biologics (HTBX) Announces Presentation of Topline HS-410 Phase 2 Bladder Cancer Results

Go back to Heat Biologics (HTBX) Announces Presentation of Topline HS-410 Phase 2 Bladder Cancer Results
HEAT BIOLOGICS (NASDAQ: HTBX) Delayed: 2.83 --0 (-0%)
Previous Close $2.83    52 Week High $4.71 
Open $2.83    52 Week Low $0.40 
Day High $2.83    P/E N/A 
Day Low $2.83    EPS $-0.50 
Volume 442,793